Translocation mechanism of C60 and C60 derivations across a cell membrane
Source abstract
Abstract
Carbon-based nanoparticles (NPs) such as fullerenes and nanotubes have been extensively studied for drug delivery in recent years. The permeation process of fullerene and its derivative molecules through membrane is essential to the utilization of fullerene-based drug delivery system, but the mechanism and the dynamics of permeation through cell membrane are still unclear. In this study, coarse-grained molecular dynamics simulations were performed to investigate the permeation process of functionalized fullerene molecules (ca. 0.72 nm) through the membrane. Our results show that single functionalized fullerene molecule in such nanoscale could permeate the lipid membrane in micro-second time scale. Pristine C60 molecules prefer to aggregate into several small clusters while C60OH15 molecules could aggregate into one big cluster to permeate through the lipid membrane. After permeation of C60 or its derivatives into membrane, all C60 and C60OH15 molecules disaggregated and monodispersed in the lipid membrane. ᅟ
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Fullerene Chemistry and Applications · Carbon Nanotubes in Composites · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–182210.1126/science.1095833 ↗
2. Araghi H, Zabihi Z (2013a) Influence of impact angle on the interaction between Co 55 nanocluster and Cu (001) substrate: ionized cluster beam deposition. Comp Mater Sci 67:109–11210.1016/j.commatsci.2012.09.003 ↗
3. Araghi H, Zabihi Z (2013b) Molecular dynamics simulation of microscopic processes in Co nanocluster impact onto Cu (001) substrate. Nucl Instrum Meth B 298:13–1810.1016/j.nimb.2012.12.011 ↗
4. Bao G, Mitragotri S, Tong S (2013) Multifunctional nanoparticles for drug delivery and molecular imaging. Annu Rev Biomed Eng 15:253–28210.1146/annurev-bioeng-071812-152409 ↗
5. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–369010.1063/1.448118 ↗
6. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–67910.1016/j.cbpa.2005.10.005 ↗
7. Bond PJ, Holyoake J, Ivetac A, Khalid S, Sansom MSP (2007) Coarse-grained molecular dynamics simulations of membrane proteins and peptides. J Struct Biol 157:593–60510.1016/j.jsb.2006.10.004 ↗
8. Brigger I, Dubernet C, Couvreur P (2012) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliver Rev 64:24–3610.1016/j.addr.2012.09.006 ↗
9. Brunetti V, Bouchet LM, Strumia MC (2015) Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems. Nanoscale 7:3808–381610.1039/C4NR04438J ↗
10. Cha C, Shin SR, Annabi N, Dokmeci MR, Khademhosseini A (2013) Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano 7:2891–289710.1021/nn401196a ↗
11. Chen I, Dubnau D (2004) DNA uptake during bacterial transformation. Nat Rev Microbio 2:241–24910.1038/nrmicro844 ↗
12. Cheng R, Meng F, Deng C, Klok H-A, Zhong Z (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34:3647–365710.1016/j.biomaterials.2013.01.084 ↗
13. DeVane R, Jusufi A, Shinoda W, C-c C, Nielsen SO, Moore PB, Klein ML (2010) Parametrization and application of a coarse grained force field for benzene/fullerene interactions with lipids. J Phys Chem B 114:16364–1637210.1021/jp1070264 ↗
14. Dicheva BM, ten Hagen TLM, Seynhaeve ALB, Amin M, Eggermont AMM, Koning GA (2015) Enhanced specificity and drug delivery in tumors by cRGD-anchoring thermosensitive liposomes. Pharm Res 32:3862–387610.1007/s11095-015-1746-7 ↗
15. Eslami H, Müller-Plathe F (2013) How thick is the interphase in an ultrathin polymer film? Coarse-grained molecular dynamics simulations of polyamide-6, 6 on graphene. J Phys Chem C 117:5249–525710.1021/jp400142h ↗
16. Eslami H, Jaafari B, Mehdipour N (2013) Coarse grained molecular dynamics simulation of nanoconfined water. Chem Phys Chem 14:1063–107010.1002/cphc.201200873 ↗
17. Felice B, Prabhakaran MP, Rodríguez AP, Ramakrishna S (2014) Drug delivery vehicles on a nano-engineering perspective. Mater Sci Eng: C 41:178–19510.1016/j.msec.2014.04.049 ↗
18. Feng S-S (2014) Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devic10.1201/b15645-7 ↗
19. Giménez C et al (2015) Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Langmuir 31:3753–376210.1021/acs.langmuir.5b00139 ↗
20. Hess B, Kutzner C, Van Der Spoel D, Lindahl E (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem Theo Comput 4:435–44710.1021/ct700301q ↗
21. Hörmann K, Zimmer A (2016) Drug delivery and drug targeting with parenteral lipid nanoemulsions—a review. J Controll Release 223:85–9810.1016/j.jconrel.2015.12.016 ↗
22. Inui N, Mochiji K, Moritani K, Nakashima N (2010) Molecular dynamics simulations of nanopore processing in a graphene sheet by using gas cluster ion beam. Appl Phys A Mater Sci Process 98:787–79410.1007/s00339-009-5528-0 ↗
23. Jia G et al (2005) Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 39:1378–138310.1021/es048729l ↗
24. Johnstone TC, Suntharalingam K, Lippard SJ (2016) The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chem Rev 116:3436–348610.1021/acs.chemrev.5b00597 ↗
25. Kamaly N, Yameen B, Wu J, Farokhzad OC (2016) Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116:2602–266310.1021/acs.chemrev.5b00346 ↗
26. Kang JW, Choi KS, Kang JC, Kang ES, Byun KR, Hwang HJ (2001) Cluster deposition study by molecular dynamics simulation: Al and Cu cluster. J Vac Sci Technol A 19:1902–190610.1116/1.1379318 ↗
27. Kotyk A (2012) Cell membrane transport: principles and techniques. Springer Science & Business Media, Berlin
28. Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–1410.1016/j.addr.2013.08.008 ↗
29. Lee SJ, Jeong Y-I, Park H-K, Kang DH, Oh J-S, Lee S-G, Lee HC (2015) Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery. Int J Nanomedicine 10:5489
30. Li L, Davande H, Bedrov D, Smith GD (2007) A molecular dynamics simulation study of C60 fullerenes inside a dimyristoylphosphatidylcholine lipid bilayer. J Phys Chem B 111:4067–407210.1021/jp064982r ↗
31. Liang L, Kong Z, Kang Z, Wang H, Zhang L, Shen J-W (2016) Theoretical evaluation on potential cytotoxicity of graphene quantum dots. ACS Biomater-Sci Eng. doi: 10.1021/acsbiomaterials.6b0039010.1021/acsbiomaterials.6b00390 ↗
32. Lim D-J, Sim M, Oh L, Lim K, Park H (2014) Carbon-based drug delivery carriers for cancer therapy. Arch Pharm Res 37:43–5210.1007/s12272-013-0277-1 ↗
33. Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Canc Res 68:6652–666010.1158/0008-5472.CAN-08-1468 ↗
34. Marrink SJ, De Vries AH, Mark AE (2004) Coarse grained model for semiquantitative lipid simulations. J Phys Chem B 108:750–76010.1021/jp036508g ↗
35. Marrink SJ, Risselada J, Mark AE (2005) Simulation of gel phase formation and melting in lipid bilayers using a coarse grained model. Chem Phys Lipid 135:223–24410.1016/j.chemphyslip.2005.03.001 ↗
36. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, De Vries AH (2007) The MARTINI force field: coarse grained model for biomolecular simulations. J Phys Chem B 111:7812–782410.1021/jp071097f ↗
37. Mehdipour N, Bahri K (2013) Mesoscale simulation of water. J Iran Chem Soc 10:1123–112810.1007/s13738-013-0250-4 ↗
38. Mekaru H, Lu J, Tamanoi F (2015) Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliver Rev 95:40–4910.1016/j.addr.2015.09.009 ↗
39. Montellano A, Da Ros T, Bianco A, Prato M (2011) Fullerene C 60 as a multifunctional system for drug and gene delivery. Nanoscale 3:4035–404110.1039/c1nr10783f ↗
40. Monticelli L (2012) On atomistic and coarse-grained models for C60 fullerene. J. Chem Theo Comput 8:1370–137810.1021/ct3000102 ↗
41. Monticelli L, Kandasamy SK, Periole X, Larson RG, Tieleman DP, Marrink S-J (2008) The MARTINI coarse-grained force field: extension to proteins. J. Chem Theo Comput 4:819–83410.1021/ct700324x ↗
42. Munoz F, Alici G, Li W (2014) A review of drug delivery systems for capsule endoscopy. Adv Drug Deliver Rev 71:77–8510.1016/j.addr.2013.12.007 ↗
43. Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nature Mater 12:991–100310.1038/nmat3776 ↗
44. Natarajan JV, Nugraha C, Ng XW, Venkatraman S (2014) Sustained-release from nanocarriers: a review. J Control Release 193:122–13810.1016/j.jconrel.2014.05.029 ↗
45. Pattni BS, Chupin VV, Torchilin VP (2015) New developments in liposomal drug delivery. Chem Rev 115:10938–1096610.1021/acs.chemrev.5b00046 ↗
46. Periole X, Cavalli M, Marrink S-J, Ceruso MA (2009) Combining an elastic network with a coarse-grained molecular force field: structure, dynamics, and intermolecular recognition. J Chem Theo Comput 5:2531–254310.1021/ct9002114 ↗
47. Probst CE, Zrazhevskiy P, Bagalkot V, Gao X (2013) Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev 65:703–71810.1016/j.addr.2012.09.036 ↗
48. Qiao R, Roberts AP, Mount AS, Klaine SJ, Ke PC (2007) Translocation of C60 and its derivatives across a lipid bilayer. Nano Lett 7:614–61910.1021/nl062515f ↗
49. Raza K et al (2015) C 60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile. Int J Pharma 495:551–55910.1016/j.ijpharm.2015.09.016 ↗
50. Risselada HJ, Marrink SJ (2008) The molecular face of lipid rafts in model membranes. Proc. Nat Acad Sci 105:17367–1737210.1073/pnas.0807527105 ↗
51. Rossi G, Barnoud J, Monticelli L (2013) Partitioning and solubility of C60 fullerene in lipid membranes. Phys Scr 87:05850310.1088/0031-8949/87/05/058503 ↗
52. Saunders MG, Voth GA (2013) Coarse-graining methods for computational biology. Annu Rev Biophys 42:73–9310.1146/annurev-biophys-083012-130348 ↗
53. Shi J et al (2013) PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials 34:251–26110.1016/j.biomaterials.2012.09.039 ↗
54. Shimizu K, Kubota R, Kobayashi N, Tahara M, Sugimoto N, Nishimura T, Ikarashi Y (2013) Cytotoxic effects of hydroxylated fullerenes in three types of liver cells. Materials 6:2713–272210.3390/ma6072713 ↗
55. Sridhar A, Srikanth B, Kumar A, Dasmahapatra AK (2015) Coarse-grain molecular dynamics study of fullerene transport across a cell membrane. J Chem Phys 143:02490710.1063/1.4926668 ↗
56. Sultana S, Khan MR, Kumar M, Kumar S, Ali M (2013) Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target 21:107–12510.3109/1061186X.2012.712130 ↗
57. Sundar S, Kundu J, Kundu SC (2016) Biopolymeric nanoparticles. Sci. Technol. Adv. Mater
58. Thakare VS, Prendergast DA, Pastorin G, Jain S (2015) Carbon-based nanomaterials for targeted drug delivery and imaging. In: Targeted drug delivery: concepts and design. Springer, Berlin Heidelberg New York, pp. 615–64510.1007/978-3-319-11355-5_19 ↗
59. Trpkovic A, Todorovic-Markovic B, Trajkovic V (2012) Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damage and the role of oxidative stress. Arch Toxicol 86:1809–182710.1007/s00204-012-0859-6 ↗
60. Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185–19810.1146/annurev-med-040210-162544 ↗
61. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2012) Nanoparticles as drug delivery systems. Pharmacol Rep 64:1020–103710.1016/S1734-1140(12)70901-5 ↗
62. Wong BS, Yoong SL, Jagusiak A, Panczyk T, Ho HK, Ang WH, Pastorin G (2013) Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65:1964–201510.1016/j.addr.2013.08.005 ↗
63. Wong-Ekkabut J, Baoukina S, Triampo W, Tang IM, Tieleman DP, Monticelli L (2008) Computer simulation study of fullerene translocation through lipid membranes. Nat Nanotechnol 3:363–36810.1038/nnano.2008.130 ↗
64. Xing G et al (2004) Influences of structural properties on stability of fullerenols. J Phys Chem B 108:11473–1147910.1021/jp0487962 ↗
65. Yin Q, Shen J, Zhang Z, Yu H, Li Y (2013) Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv Drug Deliv Rev 65:1699–171510.1016/j.addr.2013.04.011 ↗
66. Yun Y, Cho YW, Park K (2013) Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Delive Rev 65:822–83210.1016/j.addr.2012.10.007 ↗
67. Zabihi Z, Araghi H (2015) Formation of nanopore in a suspended graphene sheet with argon cluster bombardment: a molecular dynamics simulation study. Nucl Instrum Meth B 343:48–5110.1016/j.nimb.2014.11.022 ↗
68. Zhang S, Chu Z, Yin C, Zhang C, Lin G, Li Q (2013a) Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. J Am Chem Soc 135:5709–571610.1021/ja3123015 ↗
69. Zhang Y, Chan HF, Leong KW (2013b) Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 65:104–12010.1016/j.addr.2012.10.003 ↗